New York State Common Retirement Fund Zai Lab LTD Transaction History

New York State Common Retirement Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$13.72 - $21.55 $342,492 - $537,952	24,963 Added 52.49%	72,520 $1.26 Million
Q1 2024 May 07, 2024	BUY	$15.95 - $26.8 $223,443 - $375,441	14,009 Added 41.76%	47,557 $762,000
Q4 2023 Feb 01, 2024	BUY	$22.97 - $30.58 $753,737 - $1 Million	32,814 Added 4470.57%	33,548 $917,000
Q3 2023 Nov 07, 2023	SELL	$22.72 - $31.49 $9,815 - $13,603	-432 Reduced 37.05%	734 $18,000
Q2 2023 Aug 07, 2023	BUY	$25.3 - $39.67 $13,206 - $20,707	522 Added 81.06%	1,166 $32,000
Q1 2023 May 02, 2023	SELL	$30.21 - $48.1 $271 - $432	-9 Reduced 1.38%	644 $21,000
Q4 2022 Jan 30, 2023	BUY	$22.28 - $38.71 $2,228 - $3,871	100 Added 18.08%	653 $20,000
Q3 2022 Nov 08, 2022	BUY	$34.2 - $51.69 $3,420 - $5,169	100 Added 22.08%	553 $19,000
Q2 2021 Aug 02, 2021	BUY	$125.11 - $180.0 $56,674 - $81,540	453 New	453 $80,000
Q4 2017 Feb 13, 2018	SELL	$21.23 - $34.09 $235,695 - $378,467	-11,102 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$27.0 - $31.11 $299,754 - $345,383	11,102	11,102 $300,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.65B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.